These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 19344510)

  • 1. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
    Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
    Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
    Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
    PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt5a as an effector of TGFβ in mammary development and cancer.
    Serra R; Easter SL; Jiang W; Baxley SE
    J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):157-67. PubMed ID: 21416313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.
    Roarty K; Serra R
    Development; 2007 Nov; 134(21):3929-39. PubMed ID: 17898001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
    Joseph H; Gorska AE; Sohn P; Moses HL; Serra R
    Mol Biol Cell; 1999 Apr; 10(4):1221-34. PubMed ID: 10198068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
    Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
    Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt5a attenuates Wnt3a-induced alkaline phosphatase expression in dental follicle cells.
    Sakisaka Y; Tsuchiya M; Nakamura T; Tamura M; Shimauchi H; Nemoto E
    Exp Cell Res; 2015 Aug; 336(1):85-93. PubMed ID: 26112214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
    Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.
    Upadhyay G; Yin Y; Yuan H; Li X; Derynck R; Glazer RI
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7820-5. PubMed ID: 21518866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking TGF-
    Nlandu-Khodo S; Neelisetty S; Phillips M; Manolopoulou M; Bhave G; May L; Clark PE; Yang H; Fogo AB; Harris RC; Taketo MM; Lee E; Gewin LS
    J Am Soc Nephrol; 2017 Dec; 28(12):3490-3503. PubMed ID: 28701516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
    Thacker PC; Karunagaran D
    PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
    Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
    Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
    Crowley MR; Frost A; Chen DT; Baffi MO; Nicola T; Serra R
    Differentiation; 2006 Feb; 74(1):40-52. PubMed ID: 16466399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.
    Meier-Abt F; Milani E; Roloff T; Brinkhaus H; Duss S; Meyer DS; Klebba I; Balwierz PJ; van Nimwegen E; Bentires-Alj M
    Breast Cancer Res; 2013 Apr; 15(2):R36. PubMed ID: 23621987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8.
    van den Bosch MH; Blom AB; van Lent PL; van Beuningen HM; Blaney Davidson EN; van der Kraan PM; van den Berg WB
    Cell Signal; 2014 May; 26(5):951-8. PubMed ID: 24463008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.